Transdermal Drug Delivery | Technological Advancements, Evolving Industry Trends and Insights

A new research report by Transparency Market Research offers a comprehensive evaluation of the global Transdermal Drug Delivery Market. The study, titled “Transdermal Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, is available for sale on the firm’s website.

Transdermal drug delivery is a mode of drug administration in which drug is administered through patient’s skin. The drugs or medicine that needs to be administered to a patient are usually applied in the form of a plaster, patch, or ointment in this administration route such that the drugs are gradually absorbed into the systemic circulation. Transdermal drug delivery systems (TDDS) are generally comprised of five key components: the drug, polymer matrix, permeation enhancers, adhesives, and backing layers.

Get accurate market forecast and analysis on the Transdermal Drug Delivery market. Request a sample to stay abreast on the key trends impacting this market@
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=158

Transdermal drug delivery system has several advantages such as:
The delivery of drug is non-invasive which is very less painful to the patient as compared to other forms of drug administration
Avoids first-pass metabolism thus increasing the bio-availability of drug
Transdermal drug delivery have fewer side effects than oral medications or supplements
Administration of complete dose of the drug is possible through TDDS
Provides controlled plasma levels of very potent drugs
Termination of therapy is easy at any point of time
Reduction in healthcare costs due to higher compliance & more effective treatment

Factors that directly affect the quality, permeation and efficacy of transdermal drug delivery include morphology and physiology of skin and the combination of skin, penetrant and delivery system.

The transdermal drug delivery market is driven by the introduction of easy-to-use and effective transdermal drug delivery systems based on cutting-edge technology. The transdermal drug delivery market is increasing due to its rising demand as it is more convenient than conventional systems for administrating drugs. For example, patients that are fanatical to oral drug dosages or those patients in unconscious state can be administered drugs through the transdermal route.

Transdermal patches provides improved control over toxicity levels as these patches can be easily peeled off if the drug is scrutinized to render higher toxic effects. Drug permeation can be monitored and estimated more effectively through this method, which makes it convenient to maintain a constant level of drug serum. In view of these factors, the adoption rate of products in the global transdermal drug delivery market is high. By application, the global transdermal drug delivery market can be classified as hormone replacement therapy, pain management, contraception, neurological disorders, and smoking cessation. Transdermal drug delivery system is one of the fastest growing segments of the total drug delivery sector as it is the most convenient drug delivery system.

Get Request For customize this Report@
http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=158

Geographically, the global transdermal drug delivery market is segmented into North America, Europe, Asia Pacific and Rest of the World. Nicotine patch is highly sold in the United States. This patch releases nicotine in controlled manner to help with the cessation of tobacco smoking. In Europe, the first commercially available vapour patch was approved in 2007 to reduce smoking habits. Transdermal patches are gaining share in the global transdermal drug delivery market penetration because primary care physicians and patients equally put more emphasis on easy to use drug delivery methods.

Some of the key global participants present in the transdermal drug delivery market include 3M Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd, Bayer Crop Science Ltd., BioGel Technology Inc., Upsher-Smith Laboratories, Inc., Johnson & Johnson Limited, Mylan Pharmaceuticals Inc., GlaxoSmithKline plc, Novartis AG, Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., Boehringer Ingelheim GmbH and Actavis Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.